TP53 and breast cancer: Asukamycin, a member of manumycin polyketides, acts as molecular glue between UBR7 and p53, targeting the interaction between the E3 ligase UBR7 and the tumor suppressor p53 in breast cancer cells and resulting in p53 transcriptional activation and cell death [269].